Extracorporeal Shock Wave Lithotripsy Market

Extracorporeal Shock Wave Lithotripsy Market Analysis

The Extracorporeal Shock Wave Lithotripsy Market size is estimated at USD 337.69 million in 2025, and is expected to reach USD 455.12 million by 2030, at a CAGR of 6.15% during the forecast period (2025-2030).

Factors driving market growth include the growing adoption of minimally invasive procedures and the growing risk factors that lead to kidney stones.

The high prevalence of kidney stone disorder in developed countries, such as the United States, is anticipated to boost market growth over the forecast period. According to the National Kidney Foundation, in 2024, more than half a million people are expected to go to emergency rooms for kidney stone problems. It is also estimated that one in ten people will have a kidney stone at some point in their lives. Such a high prevalence is anticipated to increase the adoption of extracorporeal shock wave lithotripsy devices, driving market growth.

The rising prevalence of kidney and ureter stones and the increasing demand for minimally invasive procedures are expected to fuel the ESWL market. According to an article published in the Healthcare Journal in September 2022, the global prevalence of nephrolithiasis was approximately 20% during 2022. Also, the health and economic burdens caused by kidney stone disease are enormous worldwide. Hence, there is a growing need for procedures such as lithotripsy, boosting the demand for extracorporeal shock wave lithotripsy (ESWL) devices.

Product and service launches and mergers and acquisitions are anticipated to boost market growth over the forecast period. For instance, ESWL was introduced at BHR University Hospitals in the United Kingdom in February 2023. The introduction of the ESWL machine not only enhanced patient experience but also directly supported the hospital's initiatives to reduce waiting lists of patients suffering from kidney stones.

Therefore, the growing adoption of minimally invasive procedures and the growing risk factors that lead to kidney stones are anticipated to drive market growth. However, the limitations of ESWL may restrain the growth over the forecast period.

Extracorporeal Shock Wave Lithotripsy Market Trends

The Kidney Stones Segment is Projected to Grow Significantly During the Forecast Period

Several risk factors contribute to the prevalence of kidney stones, such as obesity, metabolic disorders, intestinal injuries, certain medications, and diabetes.

According to the International Federation of Diabetics (IFD) Report 2022, the number of people with diabetes is expected to rise to 643 million by 2030 and 783 million by 2045. Moreover, the incidence of Type 2 diabetes is rising rapidly in low- and middle-income countries, affecting 79% of adults in these regions. For people with diabetes, kidney stones can be especially troublesome, as the sugar in their urine creates a breeding ground for bacteria. As a result, the increasing prevalence of diabetes and kidney stones is expected to boost the demand for kidney stone treatments over the forecast period.

One of the most common and effective treatments for kidney stones is extracorporeal shock wave lithotripsy (ESWL). This procedure involves shattering the kidney stone into smaller fragments that can quickly pass through the urinary tract and exit the body. For instance, according to the study published in the African Journal of Urology in January 2024, ESWL monotherapy is a safe and effective treatment for vesical calculi, providing patients with minimal discomfort, particularly when performed in a supine position without the routine use of a per urethral catheter.

According to the above study, ESWL should receive greater consideration from urologists managing vesical calculi. The study highlighted a notable success rate for ESWL at 93.1% after a single session, increasing to 100% after two sessions. Therefore, the high success rate of ESWL in managing kidney stones is anticipated to increase the adoption of this technique, thereby boosting the segment’s growth.

The kidney stones segment is poised for significant growth over the forecast period due to the rising incidence of kidney stones worldwide and increasing risk factors such as diabetes, obesity, and metabolic disorders. Additionally, the increased success of the ESWL technique in the management of kidney stones is expected to drive market growth.

North America is Anticipated to Hold a Significant Market Share During the Forecast Period

North America is expected to hold a significant market share in the ESWL market over the forecast period, owing to many obese and diabetic patients prone to stone formation.

According to the research study published in the Journal of Americal Urological Association in January 2024, among US adults aged 20 years and older, 9.9% (23.7 million) of individuals reported a history of kidney stones during their lifetime, and 1.8% (4.4 million) had passed a kidney stone in the past 12 months. Therefore, the high prevalence and incidence of kidney stones are anticipated to increase the adoption of non-invasive treatments such as ESLW for kidney stones, thereby propelling market growth.

Furthermore, according to the research article published by Cleaveland Clinic in April 2024, ESWL stands out as a crucial, minimally invasive alternative to surgery for large stones and offers a promising solution for complex cases. Such research studies indicate the importance of ESWL as it enhances the treatment portfolio of hospitals and expands the treatment options available to patients, thereby boosting market growth.

Thus, owing to the above-mentioned factors, such as the high prevalence of kidney stones and the significance of ESWL in treating kidney stones, the market is expected to grow over the forecast period.

Extracorporeal Shock Wave Lithotripsy Industry Overview

The market for extracorporeal shock wave lithotripsy is semi-consolidated, with several international and local companies holding significant market shares. These companies actively engage in research and development activities to introduce innovative products that offer better patient outcomes and improved efficiency. Moreover, they are also expanding their market presence through strategic collaborations, partnerships, and mergers and acquisitions. Some of the companies operating in the market include Olympus, Dornier MedTech, MTS Medical, Cook Medical, and Richard-Wolf, among others.

Extracorporeal Shock Wave Lithotripsy Market Leaders

Extracorporeal Shock Wave Lithotripsy Market News

• May 2024: Dornier Medtech, in collaboration with urologists, introduced Urogpt, an advanced AI tool designed for patients with kidney stones. This launch highlighted Dornier's commitment to digital solutions that prioritize patient needs. Urogpt represented a significant advancement in the company's mission to support individuals with kidney stones. The app provides urology patients with immediate advice and actionable insights, offering clarity and reassurance.
• February 2024: An extracorporeal shock wave lithotripsy (ESWL) machine was inaugurated at INHS Asvini's Urology Department. This advanced ESWL machine offers a non-invasive solution for fragmenting kidney stones, marking a significant improvement in the treatment of kidney stone diseases and patient care at INHS Asvini.